MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, XENE has $633,163K in assets. $51,403K in debts. $199,163K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1341.52%
Quick Ratio
1341.52%
Cash Ratio
476.56%
Debt to Asset Ratio
8.12%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities (note 5)
    • Cash and cash equivalents
    • Marketable securities, long-term...
    • Others
Liabilities Breakdown
    • Common shares, without par value...
    • Accumulated deficit
    • Additional paid-in capital
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
199,163
Marketable securities (note 5)
349,723
Other receivables
1,371
Prepaid expenses and other current assets
10,392
Total current assets
560,649
Marketable securities, long-term (note 5)
37,152
Operating lease right-of-use asset, net (note 7)
6,626
Property, plant and equipment, net (note 6)
8,721
Deferred tax assets (note 14)
12,864
Prepaid expenses, long-term
7,151
Total assets
633,163
Accounts payable and accrued liabilities (note 8)
40,260
Operating lease liability (note 7)
1,532
Total current liabilities
41,792
Operating lease liability, long-term (note 7)
6,412
Other liabilities, long-term
3,199
Total liabilities
51,403
Common shares, without par value unlimited shares authorized issued and outstanding 80,010,790 (december 31, 2024 - 76,413,086) (note 9)
1,598,571
Additional paid-in capital
228,234
Accumulated deficit
-1,245,380
Accumulated other comprehensive income (loss)
335
Total shareholders' equity
581,760
Total liabilities and shareholders equity
633,163
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities(note 5)$349,723K Cash and cashequivalents$199,163K Prepaid expenses andother current assets$10,392K Other receivables$1,371K Total current assets$560,649K Marketable securities,long-term (note 5)$37,152K Deferred tax assets (note14)$12,864K Property, plant andequipment, net (note 6)$8,721K Prepaid expenses,long-term$7,151K Operating leaseright-of-use asset, net (note...$6,626K Total assets$633,163K Total liabilities andshareholders equity$633,163K Total shareholders'equity$581,760K Total liabilities$51,403K Accumulated deficit-$1,245,380K Common shares, withoutpar value unlimited...$1,598,571K Total currentliabilities$41,792K Operating leaseliability, long-term (note...$6,412K Other liabilities,long-term$3,199K Additional paid-in capital$228,234K Accumulated othercomprehensive income (loss)$335K Accounts payable andaccrued liabilities...$40,260K Operating lease liability(note 7)$1,532K

logo_icon_teal_2280px-svg

Xenon Pharmaceuticals Inc. (XENE)

logo_icon_teal_2280px-svg

Xenon Pharmaceuticals Inc. (XENE)